Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array

Genes Chromosomes and Cancer

Volumn 42, Issue 3, 2005, Pages 287-298

  Martínez Ramírez, Angel ^a   Urioste, Miguel ^a   Melchor, Lorenzo ^a   Blesa, David ^a   Valle, Laura ^a   De Andrés, Sara Alvarez ^a   Kok, Klaas ^c   Calasanz, Maria José ^b   Cruz Cigudosa, Juan ^a   Benítez, Javier ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN BCL 2; PROTEIN BCL 6; TRANSCRIPTION FACTOR RUNX1;

ADULT; AGED; APOPTOSIS; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 18P; CHROMOSOME 18Q; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME 4P; CHROMOSOME 5P; CHROMOSOME 6Q; CHROMOSOME 8Q; CHROMOSOME DELETION 11Q; CHROMOSOME DELETION 18Q; CHROMOSOME DELETION 20Q; CHROMOSOME DELETION 5Q; CHROMOSOME DELETION 7Q; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE LOSS; HEMATOLOGIC MALIGNANCY; HUMAN; KARYOTYPE; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TELOMERE; TRISOMY 8;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; FEMALE; GENES, ERBB-2; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NUCLEIC ACID HYBRIDIZATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCL-6; PROTO-ONCOGENES; TELOMERE; TRANSCRIPTION FACTORS;

EID: 19944430603     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20154     Document Type: Article

References (31)

1. Aster JC, Longtine JA. 2002. Detection of BCL2 rearrangements in follicular lymphoma. Am J Pathol 160:759-763.
2. Baron BW, Anastasi J, Thirman MJ, Furukawa Y, Fears S, Kim DC, Simone F, Birkenbach M, Montag A, Sadhu A, Zelenik-Le N, McKeithan TW. 2001. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci USA 99:2860-2865.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Gallon DA, Gralnick HR, Sultan C. 1984. Myclodysplastic syndromes: is another classification necessary? Br J Haematol 56:515-517.
4. Cigudosa JC, Odero MD, Calasanz MJ, Sole F, Salido M, Arranz E, Martínez-Ramírez A, Urioste M, Alvarez S, Cervera JV, MacGrogan D, Sanz MA, Nimer SD, Benitez J. 2003. De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19. Genes Chromosomes Cancer 36:406-412.
5. Cuthbert G, Thompson K, McCullough S, Watmore A, Dickinson H, Telford N, Mugneret F, Harrison C, Griffiths M, Bown N. 2000. MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study. Leukemia 14:1885-1891.
6. Dohner H, Stilgenbauer S, Fischer K, Bentz M, Lichter P. 1997. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. Leukemia 11:S19-S24.
7. Fenaux P, Morel P, Lai JL. 1996. Cytogenctics of myelodysplastic syndromes. Semin Hematol 33:127-138.
8. Fernandez Y, Gu B, Martinez A, Torregrosa A, Sierra A. 2002. Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state. Int J Cancer 101:317-326.
9. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE, Smith J, Vetrie D, Gorman P, Tomlinson IP, Carter NP. 2003. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36:361-374.
10. Greenberg P, Cox C, Le Beau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C. Mufti G, Bennett J. 1997. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079-2088.
11. Grimwade D, Walker H, Oliver F, Wheatley K, Marrison C, Harrison G. Rees J, Hann I, Stevens R, Burnett A, Goldstone A. 1998. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92:2322-2333.
12. Heim S, Mitelman F. 1995. Cancer Cytogenetics. Chromosomal and molecular genetic aberrations of tumor cells. New York: Wiley-Liss.
13. Hilgenfeld F, Padilla-Nash H, McNeil N, Knutsen T, Montagna C, Tchinda J, Horst J, Ludwig WD, Serve H, Buchner T, Berdel WT, Sehrock E, Ried T. 2001. Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2. Br J Haematol 113:305-317.
14. Kakazu N, Taniwaki M, Horiike S, Nishida K, Tatekawa T, Nagai M, Takahashi T, Akaogi T, Inazawa J, Ohki M, Abe T. 1999. Combined spectral karyotyping and DAP1 banding analysis of chromosome abnormalities in myelodysplastic syndrome. Genes Chromosomes Cancer 26:336-345.
15. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
16. Kim MH, Stewart J, Devlin C, Kim YT, Boyd F, Connor M. 2001. The application of comparative genomic hybridization as an additional tool in the chromosome analysis of acute myeloid leukemia and myelodysplastic syndromes. Cancer Genet Cytogenet 126:26-33.
17. Kirchhoff M, Gerdes T, Rose H, Maahr J, Ottesen AM, Lundsteen C. 1998. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry 31:163-173.
18. Lindvall C, Nordenskjold M, Porwit A, Bjorkholm M, Blennow E. 2001. Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements. Haematologica 86:1158-1164.
19. Martínez-Ramírez A, Urioste M, Alvarez S, Vizmanos JL, Calasanz MJ, Cigudosa JC, Benitez J. 2004. Cytogenetic profile of myelodysplastic syndromes with complex karyotypes. An analysis using spectral karyotyping technique. Cancer Genet Cytogenet 153:39-47.
20. Michaux L, Wlodarska I, Stul M, Dierlamm J, Mugneret F, Herens C, Beverloo B, Verhest A, Verellen-Dumoulin C, Verhoef G, Selleslag D, Madoe V, Lecomte M, Deprijek B, Ferrant A, Delannoy A, Marichal S, Duhem C, Dicato M, Hagemeijer A. 2000. MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23. Genes Chromosomes Cancer 29:40-47.
21. Mitelman F. 1995. ISCN guidelines for cancer cytogenetics. In: Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger.
22. Mrozek K, Heinonen K, Theil KS, Bloomfield CD. 2002. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q. Genes Chromosomes Cancer 34:137-153.
23. Poppe B, Vandesompele J, Schoch C, Lindvall C, Mrózek K, Bloomfield CD, Beberlo HB, Michaux L, Dastugue N, Herens C, Yigit N, De Paepe A, Hagemeijer A, Speleman F. 2004. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood 103:229-235.
24. Rowley JD. 1998. The critical role of chromosome translocations in human leukemias. Annu Rev Genet 32:495-519.
25. Rowley JD. 1999. The role of chromosome translocations in leukemogenesis. Semin Hematol 36:59-72.
26. Sandberg AA. 1990. The chromosomes in human cancer and leukemia. New York: Elsevier Science.
27. Schoch C, Haferlach T, Bursch S, Gerstner D, Schnittger S, Dugas M, Kern W, Lüffler H, Hiddemann W. 2002. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: A detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH. Genes Chromosomes and Cancer 35:20-29.
28. Streubel B, Valent P, Jager U, Edelhauser M, Wandt H, Wagner T, Buchner T, Lechner K, Fonatsch C. 2000. Amplification of the MLL gene on double minutes a homogeneously staining region and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chromosomes Cancer 27:380-386.
29. Van Limbergen H, Poppe B, Michaux L, Herens C, Brown J, Noens L, Berneman Z, De Bock R, Dc Paepe A, Speleman F. 2002. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH. Genes Chromosomes Cancer 33:60-72.
30. Verdorfer I, Brecevic L, Saul W, Schenker B, Kirsch M, Trautmann U, Helm G, Graniatzki M, Gebhart E. 2001. Comparative genomic hybridization-aided unraveling of complex karyotypes in human hematopoietic neoplasias. Cancer Genet Cytogenet 124:1-6.
31. Ye BH, Chaganti S, Chung CC, Niu H, Corradini P, Chaganti RS, Dalla-Favera R. 1995. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. Embo J 14:6209-6217.